Sign inGet started

Rotman Harris

Insider CIK 1981420 · CNTA SVP Regulatory Affairs

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CNTA Centessa Pharmaceuticals p A Award deriv2024-02-012024-02-0275,000— $075,000SEC↗
CNTA Centessa Pharmaceuticals p A Award2024-02-012024-02-0237,500— $071,000SEC↗
CNTA Centessa Pharmaceuticals p S Sale2024-02-012024-02-024,267$8.10 $34.6K62,625SEC↗
CNTA Centessa Pharmaceuticals p F Tax w/h2024-02-012024-02-024,108$8.19 $33.6K66,892SEC↗
CNTA Centessa Pharmaceuticals p M Exercise deriv2023-09-202023-09-2231,250— $093,750SEC↗
CNTA Centessa Pharmaceuticals p M Exercise deriv2023-09-202023-09-226,234— $043,666SEC↗
CNTA Centessa Pharmaceuticals p M Exercise2023-09-202023-09-2231,250$4.47 $139.7K64,750SEC↗
CNTA Centessa Pharmaceuticals p M Exercise2023-09-202023-09-226,234$3.85 $24.0K70,984SEC↗
CNTA Centessa Pharmaceuticals p S Sale2023-09-202023-09-2237,484$6.29 $235.8K33,500SEC↗